Newsfeeds Archive - Spark Newswire

2 minute read

Movers
News

What’s Going On With Clearmind Medicine Stock Tuesday?

June 11, 12:39 PM

Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the no/low alcohol category is forecasted to grow at a volume CAGR of more than 6% between 2023 and 2027.

CMND

4 minute read

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

May 7, 2:35 PM

Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. BeyondÂ posted adjusted loss of…

ADTN

1 minute read

Movers
News

Why Clearmind Medicine Stock Is Moving Higher

By Dylan Berman

May 7, 11:03 AM

Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development.

CMND

2 minute read

Global
News

Clearmind Applies To Cease Being A Reporting Issuer In Canada

By Benzinga Newsdesk

April 30, 5:18 PM

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) ("Clearmind" or the "Company"), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve

CMND

3 minute read

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More

By Lara Goldstein

April 17, 9:13 AM

Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the first two…

AWKNF

3 minute read

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More

By Lara Goldstein

April 17, 8:42 AM

DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings The Drug Enforcement Administration (DEA)…

AGNPF

3 minute read

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

By Lara Goldstein

March 30, 8:57 AM

Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two…

CMND

4 minute read

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence

By Lara Goldstein

March 29, 12:43 PM

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have…

ATAI

1 minute read

SciSparc- Clearmind Collaboration Evolves With New International Patent Application For Preventing And Treating Depression

By Benzinga Newsdesk

March 27, 8:56 AM

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system,

CMND

2 minute read

What’s Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?

By Erica Kollmann

February 20, 2:29 PM

SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration between the companies.

CMND